Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: Borrelia

Biomedica – immunoassays

Posted on by

Biomedica is a biotech company providing high quality ELISAs in the field of cardiovascular diseases as well as bone and mineral disorders.

Biomedica – immunoassays

Biomedica Continue reading →

Posted in Biotech Companies, Biotech Companies Austria | Tagged anti oxidized LDL autoantibodies, anti oxidized LDL autoantibody, autoantibodies, autoantibody, biomarker, biomarkers, Biomedica, Biomedica - immunoassays, bone disorder, bone disorders, bone metabolism, Borrelia, C4d antibody, cardiovascular disease, cardiovascular diseases, DKK-1, ELISA, ELISAs, Endostatin, Endothelin, Endothelins, EZ4U, FGF23, glycan profiling, glycoanalysis, Glycomics, Glycotechnica, immunoassay, immunoassays, LecChip, Lectin, Lectin microarray, Lectin microarrays, Lyme Borreliosis, Lyme disease, MDA -oxidized LDL, mineral disorder, mineral disorders, natriuretic, natriuretic peptide, natriuretic peptides, NT-proANP, NT-proBNP, Osteoprotegerin, OxyStat, RANKL, Sclerostin, soluble RANKL

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress